Thyroid Hormone Status in Sitosterolemia is Modified by Ezetimibe

OBJECTIVES: To assess the association between biomarkers of thyroid status and 5α-stanols in sitosterolemia (STSL) patients treated with ezetimibe (EZE). STUDY DESIGN: Eight STSL patients (16-56 years) were studied during 14 weeks off EZE therapy (OFF EZE) and 14 weeks on EZE (10 mg/d; ON EZE). Seru...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Pediatr
Asıl Yazarlar: Othman, Rgia A., Myrie, Semone B., Mymin, David, Roullet, Jean-Baptiste, DeBarber, Andrea E., Steiner, Robert D., Jones, Peter J.H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572543/
https://ncbi.nlm.nih.gov/pubmed/28625503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2017.05.049
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller